Close

Welcome back to Stockhouse
Member Sign In

Email or Username:
Password:
Close

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
×

Get our best content in your email.

You are already a member! Please enter your password to sign in.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History  |  Analysts  |  Earnings  |  Insiders

Anheuser Busch Cos Inc T.TKM

Sector: Healthcare | Sub-Sector: Biotechnology
Primary Symbol: ABUS

Price: N/A Volume: 0
Change: N/A % Change: N/A
Day High/Low: N/A/N/A 52 Week High/Low: 34.66/9.55
Last Traded: N/A Transaction Volume:
Open: Previous Close:
Bid: Ask:
Bid Size: 0 Ask Size: 0
Market Cap: N/A Shares Out: 54.2m
PE Ratio: N/A Dividend Yield: N/A

Opinion

The Calandra Report: BioCryst Pharma, nothing to sneeze at

Thom Calandra   October 15, 2014
0 stars

Canadian Biotech comes back to life: A buyer's guide

Everything you could ever want to know about biotech, biomed and bio investments up north.

Tony Pullen   January 21, 2014
0 stars

Latest Bullboard Posts

  • BUX.cse

    0 stars

    Anyone following Biomark BUX.CSE? They have a phase 3 cancer detection system. It looks very promising. EXAS:NASDAQ has a colon cancer...

    4.5 stars


  • Fibos at 8 13 and 21

    0 stars

    Happy June folks. My last purchase at 13.79 GLTA Peace

    1.5 stars


  • RE:Low volume today

    5 stars

    http://www.sciencedaily.com/releases/2015/04/150422135748.htm?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+sciencedaily...

    4 stars


  • Low volume today

    0 stars

    This upward movement may take a bit of a breather- it's certainly been a nice move, hopefully just a little consolidation and then...

    2.5 stars


  • Sweet

    0 stars

    Yesterday's action confirms a decisive break of the slide we've endured over the last ten months, and it came on volume. What was...

    1 star